Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | TEVA | RDY | BBIO | BHC |
| Company | Supernus Pharm | Teva Pharmaceutical Industries ADR | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 31.00 | 16.93 | 81.21 | 27.40 | 5.92 |
| High | 31.44 | 17.24 | 81.98 | 27.84 | 6.04 |
| Low | 30.31 | 16.86 | 81.16 | 26.61 | 5.69 |
| Last | 30.75 | 17.10 | 81.22 | 27.05 | 5.99 |
| Change | +0.07 | +0.30 | +0.38 | +0.35 | +0.11 |
| % Change | +0.23% | +1.79% | +0.47% | +1.31% | +1.87% |
| Volume | 353,400 | 9,088,400 | 250,200 | 885,900 | 5,184,100 |
| 20-Day Average Volume | 544,610 | 9,051,925 | 249,730 | 1,664,550 | 6,401,035 |
| Previous Close | 30.68 | 16.80 | 80.84 | 26.70 | 5.88 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.32 | 16.67 | 78.57 | 26.50 | 7.13 |
| 20-Day Raw Stochastic | 88.29% | 80.00% | 88.97% | 50.10% | 54.06% |
| 20-Day Relative Strength | 67.38% | 55.68% | 66.22% | 50.64% | 35.87% |
| Weighted Alpha | +5.49 | +100.85 | +22.63 | -21.30 | -39.97 |
| Today's Opinion | 24% Buy | 80% Buy | 100% Buy | 80% Sell | 72% Sell |
| Previous Opinion | 24% Buy | 80% Buy | 100% Buy | 80% Sell | 72% Sell |
| Last Month's Opinion | 88% Sell | 80% Buy | 24% Buy | 100% Sell | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.65% since 07/19/24 | +1.73% since 07/19/24 | +3.97% since 07/19/24 | +3.28% since 07/19/24 | -21.18% since 07/19/24 |
| Low | 29.67 on 07/23/24 | 16.45 on 07/24/24 | 79.50 on 07/22/24 | 25.88 on 07/22/24 | 3.96 on 07/24/24 |
| High | 31.44 on 07/26/24 | 17.47 on 07/23/24 | 81.98 on 07/26/24 | 27.93 on 07/23/24 | 7.72 on 07/23/24 |
| 1-Month | |||||
| %Chg | +15.08% since 06/26/24 | +5.23% since 06/26/24 | +12.76% since 06/26/24 | +14.81% since 06/26/24 | -11.78% since 06/26/24 |
| Low | 25.55 on 07/03/24 | 15.62 on 07/01/24 | 73.38 on 06/27/24 | 23.22 on 06/27/24 | 3.96 on 07/24/24 |
| High | 31.44 on 07/26/24 | 17.47 on 07/23/24 | 81.98 on 07/26/24 | 29.49 on 07/17/24 | 7.72 on 07/23/24 |
| 3-Month | |||||
| %Chg | +2.26% since 04/26/24 | +23.82% since 04/26/24 | +8.95% since 04/26/24 | +8.72% since 04/26/24 | -31.23% since 04/26/24 |
| Low | 25.53 on 06/14/24 | 13.70 on 05/01/24 | 68.07 on 05/31/24 | 21.62 on 06/24/24 | 3.96 on 07/24/24 |
| High | 32.87 on 05/09/24 | 17.69 on 06/12/24 | 81.98 on 07/26/24 | 31.43 on 06/04/24 | 9.01 on 05/01/24 |
| 6-Month | |||||
| %Chg | +7.07% since 01/26/24 | +43.58% since 01/26/24 | +16.80% since 01/26/24 | -24.74% since 01/26/24 | -26.77% since 01/26/24 |
| Low | 25.53 on 06/14/24 | 11.48 on 01/30/24 | 68.07 on 05/31/24 | 21.62 on 06/24/24 | 3.96 on 07/24/24 |
| High | 35.44 on 03/21/24 | 17.69 on 06/12/24 | 81.98 on 07/26/24 | 41.04 on 02/15/24 | 11.46 on 04/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,686,602 | 19,028,368 | 13,491,630 | 4,996,344 | 2,122,621 |
| Shares Outstanding, K | 54,974 | 1,132,641 | 166,893 | 187,129 | 360,990 |
| Annual Sales | 607,520,000 | 15,846,000,000 | 3,350,000,000 | 9,300,000 | 8,757,000,000 |
| Annual Net Income | 1,320,000 | -559,000,000 | 668,000,000 | -643,200,000 | -592,000,000 |
| Last Quarter Sales | 143,640,000 | 3,819,000,000 | 835,080,000 | 211,120,000 | 2,153,000,000 |
| Last Quarter Net Income | 120,000 | -139,000,000 | 153,390,000 | -35,220,000 | -64,000,000 |
| 60-Month Beta | 0.90 | 0.90 | 0.56 | 1.06 | 0.77 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 05/08/24 | 0.48 on 05/08/24 | 0.94 on 05/07/24 | -0.05 on 05/02/24 | 0.59 on 05/02/24 |
| Latest Earnings Date | 08/06/24 | 07/31/24 | 07/24/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | 0.410 on 07/28/23 | N/A | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 11/27/17 | 07/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.45 | 19.87 | 0.00 | 1.62 |